Skip to main content
BRKR logo
BRKR
(NASDAQ)
Bruker Corporation
$56.53-- (--)
Loading... - Market loading

Bruker (BRKR) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Bruker Corporation
BRKRNasdaq Stock MarketHealthcareMedical Devices

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Company Information

CEOFrank Laukien
Founded1960
IPO DateAugust 4, 2000
Employees11,085
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Phone978 663 3660
Address
40 Manning Road Billerica, Massachusetts 01821 United States

Corporate Identifiers

CIK0001109354
CUSIP116794108
ISINUS1167941087
EIN04-3110160
SIC3826

Leadership Team & Key Executives

Dr. Burkhard Prause Ph.D.
President and Chief Executive Officer of Bruker Energy and Supercon Technologies, Inc.
Dr. Frank H. Laukien Ph.D.
Chairman, Chief Executive Officer and President
Gerald N. Herman CPA
Executive Vice President and Chief Financial Officer
Dr. Mark R. Munch Ph.D.
Corporate Executive Vice President and President of Bruker Nano Group and Corporate
Juergen W. Srega
President of Bruker CALID Group and Bruker Daltonics Division
Dr. Falko Busse Ph.D.
President of Bruker BioSpin Group
Thomas M. Bures
Chief Accounting Officer
J. Brent Alldredge J.D.
Senior Vice President, General Counsel, Secretary and Global Head of Compliance